BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15492230)

  • 1. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice.
    Schimmer AD
    Cancer Res; 2004 Oct; 64(20):7183-90. PubMed ID: 15492230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitors of apoptosis: there is more to life than Bcl2.
    Liston P; Fong WG; Korneluk RG
    Oncogene; 2003 Nov; 22(53):8568-80. PubMed ID: 14634619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling of the regulation of caspase-3 activation and degradation.
    Stucki JW; Simon HU
    J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IAP proteins: caspase inhibitors and beyond.
    Richter BW; Duckett CS
    Sci STKE; 2000 Aug; 2000(44):pe1. PubMed ID: 11752601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-2 is resistant to inhibition by inhibitor of apoptosis proteins (IAPs) and can activate caspase-7.
    Ho PK; Jabbour AM; Ekert PG; Hawkins CJ
    FEBS J; 2005 Mar; 272(6):1401-14. PubMed ID: 15752357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
    Nachmias B; Ashhab Y; Ben-Yehuda D
    Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.
    Dean EJ; Ranson M; Blackhall F; Holt SV; Dive C
    Cancer Treat Rev; 2007 Apr; 33(2):203-12. PubMed ID: 17210228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
    Watson RW; Fitzpatrick JM
    BJU Int; 2005 Dec; 96 Suppl 2():30-4. PubMed ID: 16359436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase.
    Giagkousiklidis S; Vogler M; Westhoff MA; Kasperczyk H; Debatin KM; Fulda S
    Cancer Res; 2005 Nov; 65(22):10502-13. PubMed ID: 16288043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
    Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
    Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.
    Hussain AR; Al-Jomah NA; Siraj AK; Manogaran P; Al-Hussein K; Abubaker J; Platanias LC; Al-Kuraya KS; Uddin S
    Cancer Res; 2007 Apr; 67(8):3888-97. PubMed ID: 17440103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of apoptosis proteins in hematological malignancies.
    Fulda S
    Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells.
    Kim KW; Ha KY; Lee JS; Rhyu KW; An HS; Woo YK
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2443-8. PubMed ID: 18090083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of apoptosis proteins in injury and disease.
    Lotocki G; Keane RW
    IUBMB Life; 2002 Nov; 54(5):231-40. PubMed ID: 12587973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
    Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
    Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.